FORMULATION AND EVALUATION OF MASLINIC ACID LOADED TRANSDERMAL PATCHES

Authors

  • NEHA CHOUDHORY St. Soldier Institute of Pharmacy, Lidhran Campus, Behind NIT (R. E. C), Jalandhar-Amritsar bypass NH-1 Jalandhar 144011, Punjab, India
  • TARANJIT KAUR St. Soldier Institute of Pharmacy, Lidhran Campus, Behind NIT (R. E. C), Jalandhar-Amritsar bypass NH-1 Jalandhar 144011, Punjab, India
  • AJEET PAL SINGH St. Soldier Institute of Pharmacy, Lidhran Campus, Behind NIT (R. E. C), Jalandhar-Amritsar bypass NH-1 Jalandhar 144011, Punjab, India
  • AMAR PAL SINGH St. Soldier Institute of Pharmacy, Lidhran Campus, Behind NIT (R. E. C), Jalandhar-Amritsar bypass NH-1 Jalandhar 144011, Punjab, India

DOI:

https://doi.org/10.22159/ijcpr.2021v13i6.1933

Keywords:

Controlled DDS, Transdermal DDS, Maslinic acid, Transdermal patch, Solvent evaporation method

Abstract

Objective: To develop and evaluate Transdermal patch of Maslinic acid for Transdermal drug delivery. The current study is to develop Transdermal drug delivery system.

Methods: Suitable method such as Solvent Casting Technique of Film Casting Technique are used for preparation of Transdermal patch.

Results: The prepared Transdermal patches were transparent, smooth, uniform and flexible. The method adopted for the preparation of the system was found satisfactory.

Conclusion: Various formulations were developed by using hydrophilic and hydrophobic polymers like HPMC E5 and EC respectively in single and combinations by solvent evaporation technique with the incorporation of penetration enhancer such as dimethylsulfoxide and dibutyl phthalate as plasticizer In vitro studies concluded that HPMC E5 patches has better release than that of EC patches, which may be attributed to high water vapour permeability of HPMC patches and hydrophobic nature of EC. An attempt was made to incorporate HPMC E5 and EC to the monolithic system for better release and prolong the duration of release. Formulation F7 containing an equal ratio of HPMC E5: EC (5:5) showed maximum and sustained release of 86.816±0.264 within 24 h. Kinetic models were used to confirm the release mechanism of the formulations. Maslinic acid release from the patches F1 to F7 followed non Fickian diffusion rate controlled mechanism.

Downloads

Download data is not yet available.

References

Tyle P. Drug delivery device fundamental and biomedical application. New York: Marcel Dekker; 1988. p. 386-419.

Remington’s pharmaceutical science. 17th ed. Mack Publishing Co.; 1995. p. 1644-61.

Panchagnula R. Transdermal delivery of drugs. Ind J Pharmacol. 1997;29:140-56.

Vyas SP, Roop KK. Controlled drug delivery concepts and advances. 1st ed. New Delhi: Vallabh prakash publishers; 2005. p. 411-47.

Sanap GS, Dama GY, Hande AS, Karpe SP, Nalawade SV, Kakade RS, Jadhav U. Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int J Green Pharm. 2008;2(2):129-33. doi: 10.4103/0973-8258.41189.

Juan ME, Planas JM, Ruiz-Gutierrez V, Daniel H, Wenzel U. Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells. Br J Nutr. 2008;100(1):36-43. doi: 10.1017/S0007114508882979, PMID 18298868.

Guan T, Qian Y, Tang X, Huang M, Huang L, Li Y, Sun H. Maslinic acid, a natural inhibitor of glycogen phosphorylase, reduces cerebral ischemic injury in hyperglycemic rats by GLT-1 up-regulation. J Neurosci Res. 2011;89(11):1829-39. doi: 10.1002/jnr.22671, PMID 21800347.

Chiu MH, Prenner EJ. Differential scanning calorimetry: an invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions. J Pharm Bioallied Sci. 2011;3(1):39-59. doi: 10.4103/0975-7406.76463, PMID 21430954.

Gbaguidi F, Accrombessi G, Moudachirou M, Quetin-Leclercq JQ. HPLC quantification of two isomeric triterpenic acids isolated from Mitracarpus scaber and antimicrobial activity on Dermatophilus congolensis. J Pharm Biomed Anal. 2005;39(5):990-5. doi: 10.1016/j.jpba.2005.05.030, PMID 16043321.

Khouloud AA, Wasfi MO, Najin MN. Adsorption of allopurinol and ketotifen by chitosan. AAPS PharmSciTech. 2001;2(1):27-33.

Krishnaiah YS, Satyanarayana V, Bhaskar P. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int J Pharm. 2002;247(1-2):91-102. doi: 10.1016/s0378-5173(02)00401-5, PMID 12429488.

Mukherjee B, Das S, Patra B, Layek B. Nefopam containing transdermal-matrix patches based on pressure-sensitive adhesive polymers. Pharm Technol; 2006. Available from: http://www.pharmtech.com. [Last accessed on 10 Jul 2021]

Sathyapriya LS, Jayaprakash S, Prabhu RS, Abirami A, Subramanian K, Nagarajan M. An approach to the formulation and evaluation of transdermal DDS of isoxsuprine HCl. Int J PharmSciTech. 2008;1(1):22-8.

Gupta JRD, Irchhiaya R, Garud N, Tripathi P, Dubey P, Patel JR. Formulation and Evaluation of matrix type transdermal patches of glibenclamide. IJPSDR 2009;1(1). doi: 10.25004/IJPSDR.2009.010111.

Dandagi PM, Manavi FV, Gadag AP, Mastiholimath VS, Jagdeesh T. Formulation of ransdermal drug delivery of ketotifen fumarate. Ind J Pharm Sci. 2003;65(3):239-43.

Shivhare UD, Dorlikar VP, Bhusari KP, Mathur VB, Mirani BN. Effect of polymeric compositions on pharmacotechnical properties of carvedilol transdermal film. Int J PharmSci Nanotechnol. 2009 June;1(2):457-64.

Murthy TEGK, Kishore VS. Effect of casting solvent and polymer on the permeability of propranolol hydrochloride through membrane controlled transdermal drug delivery system. Indian J Pharm Sci. 2007 September;69(5):646-50. doi: 10.4103/0250-474X.38469.

Published

15-11-2021

How to Cite

CHOUDHORY, N., T. KAUR, A. P. SINGH, and A. P. SINGH. “FORMULATION AND EVALUATION OF MASLINIC ACID LOADED TRANSDERMAL PATCHES”. International Journal of Current Pharmaceutical Research, vol. 13, no. 6, Nov. 2021, pp. 89-98, doi:10.22159/ijcpr.2021v13i6.1933.

Issue

Section

Original Article(s)